4-(4-CYCLOPROPYLNAPHTHALEN-1-YL)-1H-1,2,4-TRIAZOLE-5(4H)-THIONE, 95.0%, 10g

4-((2-Chloroethyl)(methyl)amino)benzaldehyde, 95.0%, 25g

2-[(5-amino-1,3,4-thiadiazol-2-yl)thio]-N-cyclopropylacetamide, 95.0%, 1g

Sodium deuterium oxide, 30% solution in D2O, 99.5 at%D, 10 ml, glass packaging

3-CYANO-5-METHOXYBENZOIC ACID, 95.0%, 250mg

(E)-6-(2-propyl-4-(pyridin-4-yldiazenyl)phenoxy)hexanoic acid, 98%, 1g

4-Chloro-1H-indole-3-carbaldehyde, 97.0%, 10g

N,N-Bis(2-hydroxyethyl)dodecanamide, 95.0%, 100g

tert-Butyl ((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamate, 97%, 500mg

N-isopropyl-N-methyl-1,2-ethanediamine dihydrochloride, 95.0%, 5g

3-Nitro-1H-pyrrolo[2,3-c]pyridine, 95.0%, 1g

1-methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine-3-carboxamide hydrochloride, 95.0%, 1g

(2S,4R)-1-(tert-Butoxycarbonyl)-4-(methylamino)pyrrolidine-2-carboxylic acid, 98%, 500mg